Target intelligence / Profile preview

Glycerol-3-phosphate transporter (GlpT) (GlpT)

Target
GlpT
Molecular classification
Transporter, Major Facilitator Superfamily (MFS), Organophosphate:phosphate antiporter (OPA) family
01

Overview

Glycerol-3-phosphate transporter (GlpT) is a bacterial membrane protein belonging to the Major Facilitator Superfamily (MFS) that mediates the exchange of external glycerol-3-phosphate for internal inorganic phosphate. It is primarily found in Gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa, where it plays a crucial role in nutrient acquisition by allowing the cell to utilize glycerol-3-phosphate as a carbon and phosphorus source. In clinical pharmacology, GlpT is highly significant as the primary portal for the entry of the antibiotic fosfomycin into the bacterial cell. Fosfomycin mimics the chemical structure of glycerol-3-phosphate, exploiting the GlpT transport system to reach its intracellular target, the enzyme MurA. Consequently, mutations that lead to the loss or downregulation of GlpT are a major cause of clinical resistance to fosfomycin. Structurally, GlpT is a prototypical MFS transporter with 12 transmembrane helices, and its characterization has provided fundamental insights into the alternating-access mechanism of membrane transport.

Other names
Glycerol-3-phosphate permeasesn-glycerol 3-phosphate:phosphate antiporterG3P transporterGlycerol-3-phosphate:phosphate antiporter
02

Mechanism of action

Fosfomycin acts as a structural analog of glycerol-3-phosphate and is actively transported into the bacterial cytoplasm via GlpT, where it subsequently inhibits the enzyme MurA to block cell wall synthesis.

03

Biological functions

Glycerol-3-phosphate uptakePhosphate effluxTransmembrane transportNutrient acquisition
04

Disease associations

Bacterial infectionAntibiotic resistance
05

Safety considerations

Rapid development of antibiotic resistance through loss-of-function mutations in glpTCross-resistance with other organophosphate-mimicking compounds
06

Interacting drugs

Fosfomycin
07

Biomarkers

glpT gene mutationsglpT expression levelsGlycerol-3-phosphate utilization phenotype

Beyond the preview

Go deeper on Glycerol-3-phosphate transporter (GlpT) (GlpT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycerol-3-phosphate transporter (GlpT) (GlpT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call